Filing Details

Accession Number:
0001567619-23-005291
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-03-17 21:31:45
Reporting Period:
2023-03-15
Accepted Time:
2023-03-17 21:31:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1559053 Prothena Corp Public Ltd Co PRTA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1457013 Tran Nguyen C/O Prothena Biosciences Inc
331 Oyster Point Boulevard
South San Francisco CA 94080
Chief Strategy Officer And Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares, Par Value $0.01 Per Share Acquisiton 2023-03-15 10,000 $6.73 13,200 No 4 M Direct
Ordinary Shares, Par Value $0.01 Per Share Disposition 2023-03-15 4,802 $48.16 8,398 No 4 S Direct
Ordinary Shares, Par Value $0.01 Per Share Disposition 2023-03-15 5,198 $48.68 3,200 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Stock Option (Right to Buy) Disposition 2023-03-15 10,000 $0.00 10,000 $6.73
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2023-03-31 No 4 M Direct
Footnotes
  1. The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in connection with a court stipulation and order regarding the separation of assets ("Court Order") in accordance with a divorce settlement agreement.
  2. The transaction was executed in multiple trades in prices ranging from $47.43 to $48.405, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in footnotes 2 through 3 of this Form 4.
  3. The transaction was executed in multiple trades in prices ranging from $48.43 to $49.03, inclusive.
  4. The option was granted on April 1, 2013 and all shares subject to the option were fully vested and exercisable. The option will expire in approximately one month and be forfeited to the extent it is not exercised on or prior to March 31, 2023.
  5. The Reporting Person holds options that give him the right to acquire an aggregate of 901,837 shares at exercise prices ranging from $6.73 to $52.97, of which 721,837 are currently exercisable, and 180,000 are currently unexercisable but vest over time, subject to the Reporting Person's continued employment with the Issuer on each applicable vesting date of each option award. Certain of these options are subject to the Court Order.